相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata
M. Broadstock et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Spinal metabotropic glutamate receptor 4 is involved in neuropathic pain
Hua Wang et al.
NEUROREPORT (2011)
An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction
Stephen P. East et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)
Darren W. Engers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
Susan Duty
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease
P. J. Austin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra
Joanna Iczkiewicz et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation
Francesca Fallarino et al.
NATURE MEDICINE (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead
Richard Williams et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4):: Part I.: Discovery of pyrazolo[3,4-d] pyrimidines as novel mGluR4 positive allosteric modulators
Colleen M. Niswender et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo
Nicholas MacInnes et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
Colleen M. Niswender et al.
MOLECULAR PHARMACOLOGY (2008)
Inflammation as a causative factor in the aetiology of Parkinson's disease
P. S. Whitton
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo
Anthony C. Vernon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model
S. Breit et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Giuseppe Battaglia et al.
JOURNAL OF NEUROSCIENCE (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease
AC Vernon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons
O Valenti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus
F Windels et al.
JOURNAL OF NEUROSCIENCE (2005)
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response
L Alvarez et al.
BRAIN (2005)
Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes
HH Yao et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease
A Peppe et al.
JOURNAL OF NEUROSURGERY (2004)
Glutamate receptors and Parkinson's disease - Opportunities for intervention
MJ Marino et al.
DRUGS & AGING (2003)
Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS
C Corti et al.
NEUROSCIENCE (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Increase in level of tumor necrosis factor-α in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506
M Mogi et al.
NEUROSCIENCE LETTERS (2000)
分享论文
